International Flavors & Fragrances (0RF3) AI Stock Analysis
International Flavors & Fragrances
(LSE:0RF3)
No summary available
International Flavors & Fragrances (0RF3) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- EUR 22.37B
- Dividend Yield
- 1.93%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 115.4
- Beta (1Y)
- ―
- Revenue Growth
- -20.98%
- EPS Growth
- ―
- Country
- UK
- Employees
- 21,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
International Flavors & Fragrances Business Overview & Revenue Model
Company Description
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer good...
International Flavors & Fragrances Earnings Call Summary
The call was predominantly positive. IFF reported broad-based third-quarter growth, improved margins and cash flow, raised the lower ends of its full-year guidance ranges, advanced its portfolio transformation, and highlighted strong innovation and customer wins. The main challenges were soft Health markets, fourth-quarter profitability pressure, input-cost inflation, pricing recovery timing, modestly higher leverage, and geopolitical uncertainty in the Middle East.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
The company now expects full-year sales of approximately $7.5 billion to $7.6 billion and adjusted operating EBITDA of $1.55 billion to $1.6 billion; in Q4, it expects continued sales growth driven by volume increases, with sales around that 3%ish number plus or minus, while Q4 profitability margin is expected to moderate sequentially, partly due to seasonality where Q4 margin is the lowest of the year and due to higher costs and investments, specifically in Health & Biosciences. Q4 net price to input costs is expected to be unfavorable, with the biggest gap in Q1 and an improvement each quarter as the company progresses through 2027; the 3%ish number for 2027 raw material inflation feels right. In a normalized environment, the 4-6% top line range is viewed as doable for scent, taste, and Health & Biosciences, while biosciences is expected to continue to grow high single digits.
International Flavors & Fragrances Risk Analysis
International Flavors & Fragrances disclosed 23 risk factors in its most recent earnings report. International Flavors & Fragrances reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksInternational Flavors & Fragrances Peers Comparison
Overall Rating
BCPC79Outperform
EMN65Neutral
ESI62Neutral
SXT62Neutral
SCL55Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | $5.58B | 34.19 | 13.21% | 0.53% | 9.42% | 16.31% | |
| 65Neutral | $7.47B | 11.92 | 10.63% | 4.97% | 0.40% | -6.58% | |
| 62Neutral | $8.51B | 39.56 | 7.39% | 0.96% | 39.62% | -14.83% | |
| 62Neutral | $4.97B | 31.45 | 13.66% | 1.30% | 9.54% | 21.44% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 55Neutral | $1.56B | 371.84 | 0.36% | 2.24% | 10.02% | -90.50% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:0RF3 | International Flavors & Fragrances | 142.38 | 0.00 | 0.00% | |
| BCPC | Balchem | 182.58 | 31.28 | 20.67% | |
| EMN | Eastman Chemical Company | 67.61 | 10.81 | 19.03% | |
| SXT | Sensient | 125.82 | 35.26 | 38.93% | |
| SCL | Stepan Company | 70.65 | 29.16 | 70.28% | |
| ESI | Element Solutions | 33.44 | 6.92 | 26.11% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.